skip to Main Content

Mayo Researchers Land Patent For Non-Invasive Pancreatic Cancer Test

Newsfeed image, light gray text on dark gray background
The same Mayo Clinic research team that developed the Cologuard DNA-based stool test for colorectal cancer has also been working on similar technology for the early detection of pancreatic cancer.

After encouraging early studies, they have now landed a patent for their methods.

Dr. David Ahlquist, a Mayo Clinic medical professor and consultant in its division of gastroenterology and hepatology, led the team that, late in the last decade, developed the genomic science behind the Cologuard test, which Mayo licensed in 2009 to Exact Sciences Corp. (NASDAQ: EXAS) of Madison, Wisconsin. Read more . . .

Back To Top